87 results
Page 2 of 5
8-K
EX-4.2
aq8v908c 8u8v4v
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-4.1
tqa6b9 d8j1
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
pjj69azwct
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
tlxfgck5c4qtii8vlz2
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
wdbjm66zsk es
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K/A
yn3ey61
16 Jun 21
Submission of Matters to a Vote of Security Holders
6:05am
8-K
EX-99.1
7jhc5vf7
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
EX-10.1
st4sq2pbjhf6kmoylnf
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
yxmis 8xvfvir2
26 Jun 20
Registration of securities for employees
5:01pm
424B5
a6kh5qwux8n
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
e4hixfg4x5sloajmavy
23 Jun 20
Prospectus supplement for primary offering
4:06pm